Solventum completes $4.0B sale of Purification & Filtration business to Thermo Fisher

Solventum Corp

Completed sale of P&F business to Thermo Fisher for $4.0B cash on September 1, 2025.
Net proceeds of $3.4B primarily to pay down outstanding debt; accelerates debt reduction.
Updated FY2025 guidance: adjusted EPS raised to $5.88-$6.03 from $5.80-$5.95.
Net interest expense now expected at $400M (down from $450M); operating margin toward 20%-21% high-end.
Organic sales growth unchanged at +2.0% to +3.0%; free cash flow maintained at $450M-$550M.

item 2.01item 7.01item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.